Dana-Farber physicians including Dr. Barrett Rollins and Dr. Kenneth C. Anderson talked about the next generation of cancer-fighting drugs at the 14th annual Breakfast with the Doctors in Palm Beach.
Edward J. Benz, Jr. and Dr. Katherine Janeway commented on the benefit of
President Obama’s Precision Medicine Initiative that will benefit research at
Tags: Genomics, Genetics
Dana-Farber was mentioned in a story about how bureaucracy and outdated rules often block potential breakthroughs, but precision medicine is providing hope.
Tags: BasicResearch, Genomics, Genetics
Dana-Farber was mentioned as one of the cancer centers taking samples of patient’s tumors to analyze with new molecular diagnostic tests and identify a mutation with the hope of matching it with an effective drug.
Dana-Farber plans to expand precision medicine research by moving some staff into the new Longwood Center. Several research programs will now be under one roof.
Tags: BasicResearch, Genomics
Dr. David Steensma led research that developed a new test providing a tumor’s molecular profile, checking samples for 95 specific genes often mutated in blood cancers.
Researchers at Dana-Farber’s Center for Cancer Systems Biology produced a new human interactome map, based on a systematic screen of 13,000 human proteins that uncovered 14,000 protein-protein interactions.
Rafael Irizarry, PhD, co-led a new study investigating all stages and types of cancers that appear to share a telltale signature of widespread changes to the epigenome.
Dana-Farber has launched an extensive research project into cancer genomics.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: